ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 21st, 2022 • iBio, Inc. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of September 16, 2022 (the “Execution Date”) by and between IBIO, INC., a Delaware corporation (“Purchaser”), and RUBRYC THERAPEUTICS, INC., a Delaware corporation (“Seller”). Purchaser and Seller are referred to in this Agreement individually as a “Party” and together as the “Parties”. Capitalized terms in this Agreement have the respective meanings given to them in Section 1.1 or the other applicable provisions of this Agreement (including this preamble).
